Translational research key to realising value of university IP, says UCL biopharma chief
Dr Richard Fagan of University College London Business tells IAM about the process of turning patents for early-stage research into investable assets
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.